Published in J Clin Microbiol on November 01, 1998
Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev (2002) 2.86
Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay. Clin Diagn Lab Immunol (2001) 1.18
Overview of the diagnosis of cytomegalovirus infection. Infect Disord Drug Targets (2011) 1.11
Prenatal diagnosis of congenital cytomegalovirus infection. J Clin Microbiol (1998) 1.10
Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer. J Clin Microbiol (2000) 0.93
Reactivity to p52 and CM2 recombinant proteins in primary human cytomegalovirus infection with a microparticle agglutination assay. Clin Diagn Lab Immunol (2000) 0.89
Cytomegalovirus infection in pregnancy: should all women be screened? Rev Obstet Gynecol (2010) 0.85
Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers. Clin Diagn Lab Immunol (2001) 0.85
Clinical evaluation of the Roche Elecsys CMV IgG Avidity assay. Eur J Clin Microbiol Infect Dis (2014) 0.80
Long-term persistence of immunoglobulin A (IgA) and IgM antibodies against human cytomegalovirus in solid-organ transplant recipients. Clin Diagn Lab Immunol (1999) 0.75
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection. J Immunol Res (2016) 0.75
Magnitude of the Cytomegalovirus infection among pregnant women attending antenatal clinics in the city of Mwanza, Tanzania. BMC Res Notes (2017) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol (1990) 16.31
Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann Intern Med (1981) 3.85
Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol (1988) 3.76
Comparative study of diagnostic procedures for congenital cytomegalovirus infection. Pediatrics (1980) 3.53
Direct enzyme-linked immunosorbent assay that uses peroxidase-labeled antigen for determination of immunoglobulin M antibody to cytomegalovirus. J Clin Microbiol (1981) 1.73
Human cytomegalovirus structural proteins. J Gen Virol (1994) 1.63
Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin Diagn Lab Immunol (1997) 1.61
Correlation between immunofluorescent detection of human cytomegalovirus immediate early antigens in polymorphonuclear leukocytes and viremia. J Infect Dis (1989) 1.59
Kinetics of specific immunoglobulins M, E, A, and G in congenital, primary, and secondary cytomegalovirus infection studied by antibody-capture enzyme-linked immunosorbent assay. J Clin Microbiol (1988) 1.52
Immunoglobulin M antibodies detected by enzyme-linked immunosorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and newborn infants. J Clin Microbiol (1985) 1.48
Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis (1995) 1.42
Analysis of the humoral response to the flagellin protein of Borrelia burgdorferi: cloning of regions capable of differentiating Lyme disease from syphilis. J Clin Microbiol (1993) 1.39
Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients. J Infect Dis (1990) 1.29
Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens. J Clin Microbiol (1994) 1.29
Enzyme-linked immunoadsorbent assay for the detection of cytomegalovirus-IgM: comparison between eight commercial kits, immunofluorescence, and immunoblotting. J Clin Lab Anal (1992) 1.29
Large-scale screening of human sera with cytomegalovirus recombinant antigens. J Clin Microbiol (1990) 1.25
Antibodies to human cytomegalovirus structural polypeptides during primary infection. J Virol Methods (1988) 1.23
An enzyme labelled nuclear antigen immunoassay for detection of cytomegalovirus IgM antibodies in human serum: specific and non-specific reactions. J Med Virol (1987) 1.19
Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection. Arch Virol (1989) 1.17
The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infection. J Clin Microbiol (1995) 1.12
Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection. J Infect Dis (1988) 1.11
Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay. J Clin Microbiol (1995) 1.10
IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients. J Med Virol (1996) 1.09
Antibodies to cytomegalovirus in renal allograft recipients: correlation with isolation of virus. J Clin Pathol (1989) 1.08
A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection. J Clin Microbiol (1997) 1.07
Prokaryotic expression of a large fragment of the most antigenic cytomegalovirus DNA-binding protein (ppUL44) and its reactivity with human antibodies. J Virol Methods (1994) 1.02
A DNA-nicking activity associated with the nucleocapsid of human cytomegalovirus. Arch Virol (1982) 0.97
Human cytomegalovirus replication correlates with differentiation in a hematopoietic progenitor cell line and can be modulated by HIV-1. Arch Virol (1994) 0.95
Detection of serum immunoglobulin M to human cytomegalovirus by western blotting correlates better with virological data than detection by conventional enzyme immunoassay. Clin Diagn Lab Immunol (1996) 0.93
The DNA-binding protein pUL57 of human cytomegalovirus: comparison of specific immunoglobulin M (IgM) reactivity with IgM reactivity to other major target antigens. Clin Diagn Lab Immunol (1996) 0.92
Search for cytomegalovirus-specific immunoglobulin M: comparison between a new western blot, conventional western blot, and nine commercially available assays. Clin Diagn Lab Immunol (1997) 0.90
Construction of a polyepitope fusion antigen of human cytomegalovirus ppUL32 and detection of specific antibodies by ELISA. New Microbiol (1995) 0.89
Immunoglobulin A and M patterns to human cytomegalovirus during recurrent infection in patients with AIDS using a modified western blot. J Virol Methods (1993) 0.84
Cytomegalovirus IgM antibody detection: comparison of five assays. New Microbiol (1993) 0.79
Detection of cytomegalovirus-specific IGM in renal transplant recipients. J Clin Lab Anal (1989) 0.77
Mutants of S. cerevisiae defective in the maintenance of minichromosomes. Genetics (1984) 4.39
Saccharomyces cerevisiae protein involved in plasmid maintenance is necessary for mating of MAT alpha cells. J Mol Biol (1988) 4.15
Isolation and characterization of the centromere from chromosome V (CEN5) of Saccharomyces cerevisiae. Mol Cell Biol (1984) 2.36
Prenatal indicators of congenital cytomegalovirus infection. J Pediatr (2000) 2.12
Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting. J Med Virol (1985) 2.09
Calcitriol and calcium carbonate therapy in early chronic renal failure. Nephrol Dial Transplant (1994) 2.03
Identification and procaryotic expression of the gene coding for the highly immunogenic 28-kilodalton structural phosphoprotein (pp28) of human cytomegalovirus. J Virol (1988) 2.00
Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay. J Clin Microbiol (2000) 1.92
Human cytomegalovirus structural proteins. J Gen Virol (1994) 1.63
Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin Diagn Lab Immunol (1997) 1.61
West Nile virus in Europe: emergence, epidemiology, diagnosis, treatment, and prevention. Clin Microbiol Infect (2013) 1.58
Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut (2000) 1.53
Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August-September 2009. Euro Surveill (2009) 1.48
Organization of a cluster of erythromycin genes in Saccharopolyspora erythraea. J Bacteriol (1990) 1.42
The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients. Atherosclerosis (1991) 1.40
Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol (2005) 1.33
Human cytomegalovirus morphogenesis: an ultrastructural study of the late cytoplasmic phases. Arch Virol (1988) 1.33
Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg (2005) 1.30
Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection. Clin Diagn Lab Immunol (1999) 1.29
Enzyme-linked immunoadsorbent assay for the detection of cytomegalovirus-IgM: comparison between eight commercial kits, immunofluorescence, and immunoblotting. J Clin Lab Anal (1992) 1.29
Analysis of intracellular and intraviral localization of the human cytomegalovirus UL53 protein. J Gen Virol (2002) 1.27
Identification and preliminary use of recombinant lambda gt11 fusion proteins in human cytomegalovirus diagnosis. J Gen Virol (1989) 1.26
Modulation of RANTES production by human cytomegalovirus infection of fibroblasts. J Virol (1997) 1.25
Large-scale screening of human sera with cytomegalovirus recombinant antigens. J Clin Microbiol (1990) 1.25
Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol (2003) 1.24
Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A. J Virol (1996) 1.22
Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection. J Clin Microbiol (1989) 1.20
Human cytomegalovirus late-phase maturation is blocked by stably expressed UL32 antisense mRNA in astrocytoma cells. J Gen Virol (1997) 1.19
Mutation and cloning of eryG, the structural gene for erythromycin O-methyltransferase from Saccharopolyspora erythraea, and expression of eryG in Escherichia coli. J Bacteriol (1990) 1.19
Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay. Clin Diagn Lab Immunol (2001) 1.18
Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients. Eur J Vasc Endovasc Surg (2006) 1.16
Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene. J Virol (1995) 1.15
Oa1 knock-out: new insights on the pathogenesis of ocular albinism type 1. Hum Mol Genet (2000) 1.15
Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large Italian hospital: surveillance period 1 March - 30 September 2010. Euro Surveill (2011) 1.14
Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. Rheumatology (Oxford) (2001) 1.14
Expression and characterization of a novel structural protein of human cytomegalovirus, pUL25. J Virol (1999) 1.14
Early enhanced glucose uptake in human cytomegalovirus-infected cells. J Gen Virol (1984) 1.13
Serum antibodies to individual cytomegalovirus structural polypeptides in renal transplant recipients during viral infection. Microbiol Immunol (1986) 1.12
Prenatal diagnosis of congenital cytomegalovirus infection. J Clin Microbiol (1998) 1.10
Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay. J Clin Microbiol (1995) 1.10
IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients. J Med Virol (1996) 1.09
Quantitative immunolocalization of a P29 protein (GRA7), a new antigen of toxoplasma gondii. J Histochem Cytochem (1998) 1.08
A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection. J Clin Microbiol (1997) 1.07
Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol (2000) 1.07
gpUL73 (gN) genomic variants of human cytomegalovirus isolates are clustered into four distinct genotypes. J Gen Virol (2001) 1.05
Human cytomegalovirus proteins. Prog Med Virol (1988) 1.02
Prokaryotic expression of a large fragment of the most antigenic cytomegalovirus DNA-binding protein (ppUL44) and its reactivity with human antibodies. J Virol Methods (1994) 1.02
Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clin Microbiol Infect (2011) 0.98
Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation (1995) 0.98
A DNA-nicking activity associated with the nucleocapsid of human cytomegalovirus. Arch Virol (1982) 0.97
Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol (2000) 0.97
Outbreak of NDM-1-producing Enterobacteriaceae in northern Italy, July to August 2011. Euro Surveill (2011) 0.96
Human cytomegalovirus structural proteins: immune reaction against pp150 synthetic peptides. J Clin Microbiol (1991) 0.95
Post-ARDS pulmonary fibrosis in patients with H1N1 pneumonia: role of follow-up CT. Radiol Med (2011) 0.95
Human cytomegalovirus replication correlates with differentiation in a hematopoietic progenitor cell line and can be modulated by HIV-1. Arch Virol (1994) 0.95
Comparison of immunoblotting with other serological methods and virus isolation for the early detection of primary cytomegalovirus infection in allograft recipients. J Clin Microbiol (1989) 0.95
Male reproductive phenotypes in double mutant mice lacking both FSHbeta and activin receptor IIA. Endocrinology (2001) 0.94
Mendelian randomization supports causality between maternal hyperglycemia and epigenetic regulation of leptin gene in newborns. Epigenetics (2015) 0.94
Congenital cytomegalovirus infection: patterns of fetal brain damage. Clin Microbiol Infect (2012) 0.94
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group. Arterioscler Thromb (1993) 0.93
Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer. J Clin Microbiol (2000) 0.93
Detection of serum immunoglobulin M to human cytomegalovirus by western blotting correlates better with virological data than detection by conventional enzyme immunoassay. Clin Diagn Lab Immunol (1996) 0.93
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group. Arterioscler Thromb (1992) 0.92
The DNA-binding protein pUL57 of human cytomegalovirus: comparison of specific immunoglobulin M (IgM) reactivity with IgM reactivity to other major target antigens. Clin Diagn Lab Immunol (1996) 0.92
An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomegalovirus. J Med Virol (1993) 0.92
Retrospective screening of solid organ donors in Italy, 2009, reveals unpredicted circulation of West Nile virus. Euro Surveill (2010) 0.91
Construction of polyepitope fusion antigens of human cytomegalovirus ppUL32: reactivity with human antibodies. J Clin Microbiol (1994) 0.91